Aura Biosciences, Inc.
Company Stats
- Market Cap
- $651.3M
- as of Sep 30, 2026
- Shares Outstanding
- 103.7M
- Free Float
- 94.0%
Income Statement
- Operating Income
- -$112.8M
- Net Income
- -$106.2M
- EBITDA
- -$111.7M
Cash Flow
- Free Cash Flow
- -$85.2M
- FCF Yield
- -13.1%
- Owner FCF Yield
- -15.3%
Balance Sheet
- Cash & Equivalents
- $59.5M
Returns & Capital
- SBC, 3Y Avg
- $11.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$85.2M | — |
| FY2024 | — | -$81.1M | — |
| FY2023 | — | -$64.6M | — |
| FY2022 | — | -$55.7M | — |
| FY2021 | — | -$34.5M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges